Skip to Content

Pfizer seeks vaccine authorization for kids ages six months to five years

(KYMA, KECY) - Pfizer and BioNTech have asked the food and drug administration for emergency use authorization for their COVID-19 vaccine in children ages six months to five years.

Trial results released last week show the vaccine appears safe and has a strong immune response.

A month after the children in the trial got their third dose, tests showed the vaccine produced a similar immune response as two doses in 16- to 25-year-olds..

Trial results also show the vaccine had an 80.3% efficacy rate against symptomatic COVID-19 in this youngest age group.

However, more testing is needed to finalize the efficacy rate.

Article Topic Follows: Vaccine

Jump to comments ↓

Author Profile Photo

April Hettinger

April was born and raised in San Diego where she loved the beach town and her two dogs, Lexi and Malibu. She decided to trade the beach for the snow and advanced her education at Northern Arizona University in Flagstaff.


KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content